BioWorld - Tuesday, March 24, 2026

BioWorld Science

Nov. 16, 2021

View Archived Issues

AAV-TNALP-D10 shows potential as one-time-dose treatment in murine model of hypophosphatasia

Read More

Cold exposure ameliorates active experimental autoimmune encephalomyelitis

Read More

Takinib inhibits STAT3 activation and shows promise for treating rheumatoid arthritis

Read More

IL-40 is upregulated in rheumatoid arthritis and decreases following depletion therapy

Read More

Targeting NNMT as novel therapeutic strategy for fibrotic diseases

Read More

Sumitomo Dainippon Pharma patents new compounds for epilepsy

Read More

Roche discloses GABA-A receptor PAMs

Read More

Taiho Pharmaceutical presents new GTPase KRAS mutant inhibitors

Read More

Plexxikon identifies new CD73 inhibitors

Read More

C4X Discovery Holdings patents NFE2L2 activators

Read More

BioArctic developing antibody treatments targeting TDP-43 for ALS

Read More

Enhancing endothelial cell S1PR1 signaling attenuates arthritis in vivo

Read More

CPI-381: a first-in-class TREX1 inhibitor with antitumor activity in preclinical models

Read More

BAY-56-6544 improves vasomotor function in accelerated-aging model

Read More

Rat model mimics the features of cerebral small vessel disease

Read More

Soluble ACE2 decoy peptide ameliorates SARS-CoV-2 lung vascular injury

Read More

AASLD meeting: Cholangiocytes can induce liver regeneration

Read More